| Literature DB >> 26554720 |
Eric J Kort1,2,3, Lacey Croskey4, Taryn Scibienski4, Surender Rajasekaran4,5, Stefan Jovinge6,4,7.
Abstract
Circulating progenitor cells have been extensively studied in the context of heart disease in adults. In these patients, they have been demonstrated to be markers of myocardial injury and recovery as well as potential therapeutic agents. However, studies in children are much more limited. Here we review current knowledge pertaining to circulating progenitor cells in the context of childhood cardiovascular disease. Priorities for further research are also highlighted.Entities:
Keywords: Cardiopulmonary bypass; Congenital heart disease; Progenitor cells; Stem cells
Mesh:
Substances:
Year: 2015 PMID: 26554720 DOI: 10.1007/s00246-015-1300-8
Source DB: PubMed Journal: Pediatr Cardiol ISSN: 0172-0643 Impact factor: 1.655